Palisade Bio (PALI) has released an update to notify the public and investors about the unregistered sales of equity securities.
The current report details the incorporation of previously reported information regarding the issuance of Replacement Warrants and a Placement Agent Warrant. This issuance was conducted under an exemption from registration requirements as per Section 4(a)(2) of the Securities Act of 1933.
For further insights into PALI stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
